Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis. - Wikidata - awgldk - TriplyDB

Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.

Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.

http://www.wikidata.org/entity/Q35867177

about

Possibilities and challenges for developing a successful vaccine for leishmaniasis Can biowarfare agents be defeated with light?Identifying vaccine targets for anti-leishmanial vaccine development Mimotope-based vaccines of Leishmania infantum antigens and their protective efficacy against visceral leishmaniasis.An overview on Leishmania vaccines: A narrative review article.Adjuvants for Leishmania vaccines: from models to clinical application.X-ray Irradiated Vaccine Confers protection against Pneumonia caused by Pseudomonas aeruginosa Live attenuated Leishmania donovani p27 gene knockout parasites are nonpathogenic and elicit long-term protective immunity in BALB/c mice.Vaccine Development Against Leishmania donovani.From the draining lymph node to the liver: the induction and effector mechanisms of malaria-specific CD8+ T cells.Vaccine prospects of killed but metabolically active Leishmania against visceral leishmaniasis.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.

P2860

Q26749758-F5515CFB-84E8-473A-9BD0-5493824DB313 Q28396096-43182E43-822E-498A-AEBC-B6839CBE2706 Q33693899-1C40BEE2-3C02-4466-9A63-75523F88B317 Q34344080-377E1CF2-70F7-467B-80C8-E53C365BB741 Q35517074-AB55C5BD-37C1-476C-9FF5-3B83E36EAE7F Q36021357-C8BBD2C8-53D9-4A02-A05B-CFAF47189DF3 Q36583078-A330C577-098F-422E-81B5-622795CA29A8 Q36625975-D5EF4396-248E-4329-8FB4-E49BE9875238 Q38012112-BA30AB44-C547-403F-92F4-B2638BCFEFB3 Q38445061-DADEEE53-F044-4D4F-AAD8-DD6F2CFD7172 Q39202691-B893E819-29ED-4701-B4AC-8F9C9A4CE5E0 Q50130388-2BF9CEE5-5B31-46E5-86EA-00F8640D5327

P2860

Killed but metabolically active Leishmania infantum as a novel whole-cell vaccine for visceral leishmaniasis.

http://www.wikidata.org/entity/Q35867177

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@ast

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@en

type

label

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@ast

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@en

prefLabel

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@ast

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@en

P1433

Q35867177-6746E30B-9A20-4B3B-9F65-D778FC06BD5E

P1476

Q35867177-8F9CC8CD-7D45-4E7B-B356-F8B27ADCD4F7

P2093

Q35867177-0062C60D-7115-4E60-93DA-17F67B0B29D5

Q35867177-0CB9BB36-B3FF-46B7-8EC9-B2A916E05129

Q35867177-119D8089-72EF-4183-9355-7A63B234A17B

Q35867177-5BCE91A7-6B03-4A0F-B4EC-D0D71584A2F2

Q35867177-779C2588-4DAF-49EE-94EB-1A89DF8FF8D0

Q35867177-77DDF2A1-803A-4F7A-9718-B859E5B5F025

Q35867177-B0D95609-C3BA-429C-A746-091EE7D5A292

Q35867177-BD379556-04B8-494F-9E2B-0833C16D28E6

Q35867177-DB15C019-72E3-4ACA-8F14-A4F8BB8EA4BB

Q35867177-DE1E24ED-9643-462F-87A7-44E6604268DC

P2860

Q35867177-0594691E-9F51-4688-867B-F2AA844501CB

Q35867177-169E96AF-75B2-473A-88B7-C2C7EE24D063

Q35867177-19D035A9-9838-4A67-BA83-71ED2AA3C12E

Q35867177-1A37A03F-8861-469C-9999-01BA4E36E744

Q35867177-1E53ED67-3607-4A98-84B5-D1E78ADBA653

Q35867177-1F3BE848-7936-432D-A7DB-3EB8331E84C6

Q35867177-26E07581-D54D-46EA-9BF2-2E89169854D1

Q35867177-2E72F8D9-7D76-41F7-ADCA-BFA638DE2CC7

Q35867177-32ADD329-AE04-406F-A31E-D84CEB9AD0D6

Q35867177-35285264-01EF-412A-BE73-621E82DB7242

P304

Q35867177-71E7B11D-44EF-4D0B-B2F9-32210189D88D

P31

Q35867177-E36BC595-52D3-4FDF-8438-ABBEEDD204CA

P356

Q35867177-F950AA9E-BFEC-4946-A940-082F3BA79539

P433

Q35867177-E4BDD6C0-B0CB-4378-AB10-DC2DEF672CFB

P478

Q35867177-00A6A834-6BD3-4670-9289-C26DF88DBE9C

P50

Q35867177-4B7F5E0A-E5CC-4AEC-A117-F58FF3F8A8A7

P577

Q35867177-0565B9FB-C6FD-4A02-AA17-E5336BBF0831

P698

Q35867177-77D361BE-8F80-43E9-8F4F-D0D12822B337

P921

Q35867177-FDC38A47-3239-46B8-9C84-44BAD732B1B2

P932

Q35867177-D36FDDA1-FCC8-4F79-8169-261D1F45F061

P356

P1433

Clinical and Vaccine Immunology

P1476

Killed but metabolically activ ...... ne for visceral leishmaniasis.

@en

P2093

Jacquelyn Haskell

http://www.w3.org/2001/XMLSchema#string

Kevin W Bruhn

http://www.w3.org/2001/XMLSchema#string

Mary E Wilson

http://www.w3.org/2001/XMLSchema#string

Noah Craft

http://www.w3.org/2001/XMLSchema#string

Pei-Lin Chang

http://www.w3.org/2001/XMLSchema#string

Ron Birnbaum

http://www.w3.org/2001/XMLSchema#string

Rupa Narayan

http://www.w3.org/2001/XMLSchema#string

Stephanie Greger

http://www.w3.org/2001/XMLSchema#string

Suzanne M Hickerson

http://www.w3.org/2001/XMLSchema#string

Thu Anh Tran

http://www.w3.org/2001/XMLSchema#string

P2860

Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria

Genetics and visceral leishmaniasis: of mice and man

The strange case of Leishmania chagasi

Advances in leishmaniasis

Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms.

LXR deficiency confers increased protection against visceral Leishmania infection in mice.

Development of a safe live Leishmania vaccine line by gene replacement.

Conditions influencing the efficacy of vaccination with live organisms against Leishmania major infection

Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.

Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma.

P304

490-498

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/CVI.05660-11

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Stephen M. Beverley

P577

2012-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22323556

http://www.w3.org/2001/XMLSchema#string

P921

visceral leishmaniasis

P932

3318268

http://www.w3.org/2001/XMLSchema#string